EBN&Co. advised Vertex Ventures, Debiopharm, Grove Ventures and Fosun RZ Capital on the deal, while Yigal Arnon & Co. represented Nucleai. Nucleai raised $33 million in...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here